Re-Emerging Trend of Mpox Infection: The Indonesia’s Experience and Review
Abstract
Background: Since Monkeypox (mpox) had an outbreak on 6th May 2022 in 75 countries, it has been declared by the World Health Organization (WHO) that mpox is a public health of international emergency concern (PHEIC). WHO declared mpox as PHEIC again in August 204. Indonesia was also affected by the mpox outbreak with most of the cases coming from vulnerable populations. This study aimed to give an overview of mpox as well as the recent outbreak situation and management in Indonesia. Methods: In this narrative review (using PubMed, Scopus, and Cochrane databases combined with countries’ national official reports and grey literatures), we discussed an overview of mpox including epidemiology, morphology, transmission, symptoms, treatment, and prevention. The management of mpox in Indonesia was specifically reviewed. Results: Mpox is an infectious disease caused by the mpox virus which has infected 79,231 individuals globally. In Indonesia, the first mpox case was detected in August 2022 with 0 deaths and 88 confirmed cases as of August 2024. The virus is transmitted via respiratory droplets or direct contact with contaminated objects, surfaces, or mucocutaneous lesions of an infected individual which could lead to symptoms such as epidermal papules-pustules and clinical characteristics of classical smallpox. Although antivirals such as tecovirimat, cidofovir, and brincidofovir have been raised as potential treatments for mpox, these agents were only considered in severe cases in Indonesia. Conclusion: Mpox is a contagious disease that could cause major health problems if left uncontrolled, especially in specific vulnerable populations due to its high morbidity and mortality. Therefore, particular measures must be performed, especially in Indonesia.
Keywords
References
McCollum AM and Damon IK. Human monkeypox. Clin Infect Dis. 2014;58 (2):260-7.
Shchelkunov SN. An increasing danger of zoonotic orthopoxvirus infections. PLoS Pathog. 2013;9(12): e1003756.
Magnus Pv, Andersen EK, Petersen KB and Birch-Andersen A. A pox-like disease in cynomolgus monkeys. 1959;46 (2):156-76.
Breman JG, Kalisa R, Steniowski MV, Zanotto E, Gromyko AI, Arita I. Human monkeypox, 1970-79. Bull World Health Organ. 1980;58 (2):165-82.
Bunge EM, Hoet B, Chen L, et al. The changing epidemiology of human monkeypox-a potential threat? A systematic review. PLoS Negl Trop Dis. 2022;16(2): e0010141.
World Health Organization. Multi-country outbreak of monkeypox. External situational report 2, published 25 july 2022. Geneva: World Health Organization; 2022.
World Health Organization. Second meeting of the international health regulations (2005) (ihr) emergency committee regarding the multi-country outbreak of monkeypox. 2022. https://www.who.int/news/item/23-07-2022-second-meeting-of-the-international-health-regulations-(2005)-(ihr)-emergency-committee-regarding-the-multi-country-outbreak-of-monkeypox
Kementerian Kesehatan Republik Indonesia. Kasus monkeypox bertambah di Indonesia akibat sex berisiko. 2023. https://sehatnegeriku.kemkes.go.id/baca/umum/20231023/1544066/kasus-monkeypox-bertambah-di-indonesia-akibat-sex-berisiko/
Sari M and Hairunisa N. A review of the monkeypox outbreak in indonesia in 2022. Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal). 2022;11 (5):268-74.
World Health Organization. Who director-general declares mpox outbreak a public health emergency of international concern. 2024. https://www.who.int/news/item/14-08-2024-who-director-general-declares-mpox-outbreak-a-public-health-emergency-of-international-concern
Ullah M, Li Y, Munib K, Zhang Z. Epidemiology, host range, and associated risk factors of monkeypox: An emerging global public health threat. Front Microbiol. 2023;14:1160984.
Brown K, Leggat PA. Human monkeypox: Current state of knowledge and implications for the future. Trop Med Infect Dis. 2016;1(1):8.
Hobson G, Adamson J, Adler H, et al. Family cluster of three cases of monkeypox imported from nigeria to the united kingdom, May 2021. Euro Surveill. 2021; 26(32):2100745.
Ng OT, Lee V, Marimuthu K, et al. A case of imported monkeypox in singapore. Lancet Infect Dis. 2019;19 (11):1166.
Yong SEF, Ng OT, Ho ZJM, et al. Imported monkeypox, singapore. Emerg Infect Dis. 2020;26 (8):1826-30.
Huang Y, Mu L, Wang W. Monkeypox: Epidemiology, pathogenesis, treatment and prevention. Signal Transduct Target Ther. 2022;7 (1):373.
Rao AK, Petersen BW, Whitehill F, et al. Use of jynneos (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: Recommendations of the advisory committee on immunization practices - united states, 2022. MMWR Morb Mortal Wkly Rep. 2022;71 (22):734-42.
Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl Trop Dis. 2019;13 (10): e0007791.
Kapoor S, Varadharajan A. Monkeypox 2022: Emerging zoonotic epidemic threat, future implications, and way ahead. Journal of Public Health and Primary Care. 2023;4 (1):8-11.
Oladoye M. Monkeypox: A neglected viral zoonotic disease. Eur J Med Ed Te. 2021;14 (2):em2108.
Pal M, Mengstie F, Kandi V. Epidemiology, diagnosis, and control of monkeypox disease: A comprehensive review. American Journal of Infectious Diseases and Microbiology. 2024;5 (2):94-9.
Petersen E, Kantele A, Koopmans M, et al. Human monkeypox: Epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin North Am. 2019;33 (4):1027-43.
World Health Organization. Multi-country outbreak of mpox. External situation report 35, published 12 august 2024. Geneva: World Health Organization, 2024.
Centers for Disease Control and Prevention. Ongoing 2022 global outbreak cases and data. 2024. https://www.cdc.gov/poxvirus/mpox/response/2022/index.html
Formenty P, Muntasir MO, Damon I, et al. Human monkeypox outbreak caused by novel virus belonging to congo basin clade, sudan, 2005. Emerg Infect Dis. 2010;16 (10):1539-45.
Learned LA, Reynolds MG, Wassa DW, et al. Extended interhuman transmission of monkeypox in a hospital community in the republic of the congo, 2003. Am J Trop Med Hyg. 2005;73 (2):428-34.
International Federation of Red Cross and Red Crescent Societies. Emergency plan of action (epoa) car monkey-pox epidemic outbreak. International Federation of Red Cross and Red Crescent Societies, 2016.
Damon IK, Roth CE, Chowdhary V. Discovery of monkeypox in sudan. N Engl J Med. 2006;355(9):962-3.
Kementerian Kesehatan Republik Indonesia. 88 kasus konfirmasi mpox di indonesia, seksual sesama jenis jadi salah satu penyebab. 2024. https://sehatnegeriku.kemkes.go.id/baca/rilis-media/20240818/1546252/88-kasus-konfirmasi-mpox-di-indonesia-seksual-sesama-jenis-jadi-salah-satu-penyebab/
Harapan H, Ophinni Y, Megawati D, et al. Monkeypox: A comprehensive review. Viruses. 2022;14 (10).
Gong Q, Wang C, Chuai X, Chiu S. Monkeypox virus: A re-emergent threat to humans. Virol Sin. 2022;37 (4):477-82.
Desingu PA, Rubeni TP, Sundaresan NR. Evolution of monkeypox virus from 2017 to 2022: In the light of point mutations. Front Microbiol. 2022;13:1037598.
Simpson K, Heymann D, Brown CS, et al. Human monkeypox - after 40 years, an unintended consequence of smallpox eradication. Vaccine. 2020;38 (33):5077-81.
Moore MJ, Rathish B, Zahra F. Mpox (monkeypox). Statpearls. Treasure Island (FL): StatPearls Publishing, 2024.
Vivancos R, Anderson C, Blomquist P, et al. Community transmission of monkeypox in the united kingdom, april to may 2022. Euro Surveill. 2022;27 (22):2200422.
Okwor T, Mbala PK, Evans DH, Kindrachuk J. A contemporary review of clade-specific virological differences in monkeypox viruses. Clin Microbiol Infect. 2023;29 (12):1502-7.
Karagoz A, Tombuloglu H, Alsaeed M, et al. Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis. J Infect Public Health. 2023;16 (4):531-41.
Pickup DJ. Extracellular virions: The advance guard of poxvirus infections. PLoS Pathog. 2015;11(7): e1004904.
Mitjà O, Alemany A, Marks M, et al. Mpox in people with advanced hiv infection: A global case series. Lancet. 2023;401 (10380):939-49.
Kementerian Kesehatan Republik Indonesia. Technical report mpox di Indonesia tahun 2023. Jakarta: Kementerian Kesehatan Republik Indonesia, 2024.
Sinto R, Johan A, Nilasari H, Yunihastuti E, Nelwan EJ. Mpox skin lesions. Acta Med Indones. 2024;56 (1):114-5.
Kaler J, Hussain A, Flores G, Kheiri S, Desrosiers D. Monkeypox: A comprehensive review of transmission, pathogenesis, and manifestation. Cureus. 2022;14 (7): e26531.
Patel M, Adnan M, Aldarhami A, et al. Current insights into diagnosis, prevention strategies, treatment, therapeutic targets, and challenges of monkeypox (mpox) infections in human populations. Life (Basel). 2023;13 (1):249.
Centers for Disease Control and Prevention. Tecovirimat resistance in mpox patients, united states, 2022–2023. 2023. https://wwwnc.cdc.gov/eid/article/29/12/23-1146_article
Vo C, Zomorodi R, Silvera R, et al. Clinical characteristics and outcomes of patients with mpox who received tecovirimat in a new york city health system. Open Forum Infectious Diseases. 2023;10 (11):ofad552.
Centers for Disease Control and Prevention. Expanded access ind protocol: Use of tecovirimat (tpoxx®) for treatment of human non-variola orthopoxvirus infections in adults and children. Atlanta: Centers for Disease Control and Prevention, 2024.
Siegrist EA, Sassine J. Antivirals with activity against mpox: A clinically oriented review. Clin Infect Dis. 2023;76 (1):155-64.
Vistide (cidofovir) [package insert]. Foster city, CA: Gilead sciences; 2000.
Tembexa (brincidofovir) [package insert]. Whippany, NJ: Chimerix; 2021.
Kementerian Kesehatan Republik Indonesia. Pedoman pencegahan dan pengendalian mpox (monkeypox). Jakarta: Kementerian Kesehatan Republik Indonesia, 2023.
World Health Organization. Clinical management and infection prevention and control for monkeypox: Interim rapid response guidance, 10 june 2022. Geneva: World Health Organization, 2022.
Zahmatyar M, Fazlollahi A, Motamedi A, et al. Human monkeypox: History, presentations, transmission, epidemiology, diagnosis, treatment, and prevention. Front Med (Lausanne). 2023;10:1157670.
Bruno G, Buccoliero GB. Antivirals against monkeypox (mpox) in humans: An updated narrative review. Life (Basel). 2023;13 (10):1969.
Guarner J, Del Rio C, Malani PN. Monkeypox in 2022-what clinicians need to know. JAMA. 2022; 328 (2):139-40.
Meo SA, Al-Masri AA, Klonoff DC, Alshahrani AN, Al-Khlaiwi T. Comparison of biological, pharmacological characteristics, indications, contraindications and adverse effects of jynneos and acam 2000 monkeypox vaccines. Vaccines (Basel). 2022;10 (11):1971.
Kmiec D and Kirchhoff F. Monkeypox: A new threat? Int J Mol Sci. 2022;23 (14):7866.
Ogoina D, Damon I, Nakoune E. Clinical review of human mpox. Clin Microbiol Infect. 2023;29 (12):1493-501.
Hamdana AH, Mohsin H, Habib Tharwani Z, et al. Monkeypox virus and other emerging outbreaks: An overview and future perspective. Inquiry. 2023;60: 00469580231175437.
Chakraborty S, Chandran D, Mohapatra RK, et al. Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects. Int J Surg. 2022;105:106847.
Refbacks
- There are currently no refbacks.
This work is licensed under a